The rise of vaping among teens and young adults has created an urgent need for effective intervention strategies, making the FDA-approved smoking cessation pill a vital tool in the fight against nicotine addiction.In recent studies, varenicline, a well-known smoking cessation pill, has demonstrated remarkable efficacy, helping users quit vaping at rates three times higher than those relying on behavioral counseling alone.